Re: Eliquis NDA resubmission As I expected (#msg-76926354), the Eliquis CRL issued on 6/25/12 proved to be no big deal for BMY and PFE: http://news.bms.com/press-release/rd-news/fda-acknowledges-receipt-resubmission-eliquis-apixaban-new-drug-application-re The new PDUFA date is 3/17/13 (i.e. a 6-month response to the resubmission).